Glitazone drug use by diabetic patients associated with lower risk of primary and secondary brain cancer

Diabetic patients who take anti-diabetic drugs – known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.

Recipharm’s new CEO on ‘fast and furious’ changes, with eyes on GLP-1, biologics manufacturing

Just over three months into his new role as the CEO of Recipharm, Greg Behar is already making sizable changes to the CDMO’s engine. “I’ve

April 13, 2024

Doc’s Murder-for-Hire Plea; Gastroenterologist Claims Insanity; Nurse Gets 30 Years

Georgia doctor James Wan, MD, pleaded guilty to hiring a hitman he found on the dark web in a plot to murder his girlfriend, according

October 20, 2023

Healthcare Payers for the Pharmaceutical Industry | Pharma Payer

Factors such as increasing access to health information, the introduction of new medical treatments and technologies and the spike in birth rate are increasing the

October 3, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.